Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG
Primary Purpose
GERD
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
laparoscopic sleeve gastrectomy
ligamentum teres cardiopexy with sleeve gastrectomy
Sponsored by
About this trial
This is an interventional treatment trial for GERD focused on measuring de Novo GERD
Eligibility Criteria
Inclusion Criteria:
- candidate for bariatric surgery according to IFSO - APC guidelines
- No evidence (objective and subjective) of GERD
Exclusion Criteria:
- Presence of GERD either by history or by 24 hr pH study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
LSG
LSG with LTC
Arm Description
This group will receive standard laparoscopic sleeve gastrectomy
This group will receive LSG along with the novel LTC procedure
Outcomes
Primary Outcome Measures
GERD
Subjective (Gastroesophageal Reflux Disease questionnaires - GERD - Q) and objective (24 hour pH study) measurement of occurence of GERD will be done GERD - Q - Score 0-2 denotes no GERD. Score more than or equal to 3 indicates presence of GERD 24 hr pH study - Demeester score more than 14.7 is indicative of presence of GERD
Secondary Outcome Measures
Full Information
NCT ID
NCT04652336
First Posted
November 26, 2020
Last Updated
December 17, 2020
Sponsor
GEM Hospital & Research Center
1. Study Identification
Unique Protocol Identification Number
NCT04652336
Brief Title
Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG
Official Title
Randomized Controlled Trial Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG
Study Type
Interventional
2. Study Status
Record Verification Date
December 2020
Overall Recruitment Status
Unknown status
Study Start Date
December 10, 2020 (Anticipated)
Primary Completion Date
May 10, 2021 (Anticipated)
Study Completion Date
December 10, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
GEM Hospital & Research Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to investigate the effect of ligamentum teres cardiopexy on incidence of de Novo GERD.
Detailed Description
Laparoscopic Sleeve Gastrectomy (LSG) is now the most commonly performed bariatric surgery world wide. The results of LSG on outcomes of GERD are conflicting. It has been reported to increase the severity of pre existing GERD and also to cause new onset GERD in considerable number of patients.
In this study the effect of adding a novel procedure i.e. ligamentum teres cardiopexy,(LTC) to regular LSG on occurence of de Novo GERD will be investigated. de Novo GERD has been found to occur in 20% of cases post LSG.
This study is a randomized, prospective, parallel group, controlled trial to compare the effect of LSG versus LSG with LTC on occurence of de Novo GERD.
This is a single center based trial, being conducted in GEM hospital and research center, Coimbatore, Tamil Nadu, India. The trial has been approved by GEM research ethics committee.
Investigators are planning to enroll patients who are not having any objective or subjective evidence of GERD. The participants will be optimized as per institutional bariatric surgery protocol. After complete evaluation and optimization, participants will be randomized by computer generated random numbers into either LSG or LSG with LTC group.
The demographic data, preoperative GERD - Q scores, 24 hour pH study, intra operative details will be recorded. Post operative details during each follow up will be recorded, which will include excess weight loss, GERD - Q scores. At 6 months follow up repeat 24 hour pH study will be done to assess the status of GERD objectively.
The trial duration is expected to be of 1 year where in investigators will be recruiting patients for 6 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
GERD
Keywords
de Novo GERD
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
LSG
Arm Type
Active Comparator
Arm Description
This group will receive standard laparoscopic sleeve gastrectomy
Arm Title
LSG with LTC
Arm Type
Experimental
Arm Description
This group will receive LSG along with the novel LTC procedure
Intervention Type
Procedure
Intervention Name(s)
laparoscopic sleeve gastrectomy
Intervention Description
Comparator arm - will receive standard laparoscopic sleeve gastrectomy
Intervention Type
Procedure
Intervention Name(s)
ligamentum teres cardiopexy with sleeve gastrectomy
Intervention Description
experimental arm - Ligamentum teres will be divided from umbilicus to up to umbilical fissure. The ligament will then be wrapped around lower esophagus and sutured.
Primary Outcome Measure Information:
Title
GERD
Description
Subjective (Gastroesophageal Reflux Disease questionnaires - GERD - Q) and objective (24 hour pH study) measurement of occurence of GERD will be done GERD - Q - Score 0-2 denotes no GERD. Score more than or equal to 3 indicates presence of GERD 24 hr pH study - Demeester score more than 14.7 is indicative of presence of GERD
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
candidate for bariatric surgery according to IFSO - APC guidelines
No evidence (objective and subjective) of GERD
Exclusion Criteria:
Presence of GERD either by history or by 24 hr pH study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
PRAKHAR GUPTA
Phone
+919582438389
Email
mailto.guptaprakhar@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG
We'll reach out to this number within 24 hrs